Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bepantol or Corticosteroids for Hand-foot Syndrome Prophylaxis in Xeloda-treated Cancer
NCT00661102Phase 3Completed
- Sponsor
- Roche
- Start
- Dec 2008
- Primary completion
- Apr 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexpanthenol, corticosteroids in hand-foot syndrome (HFS), sponsored by Roche. Started Dec 2008; status: completed.
02
Drugs
dexpanthenolcorticosteroids
03
Conditions
hand-foot syndrome (HFS)
Beyond the preview
Go deeper on NCT00661102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00661102.